Vereb G - Search Results

1

Mammalian phosphatidylinositol 4-kinases.

Heilmeyer LM Jr, Vereb G Jr, Vereb G, Kakuk A, Szivák I. Heilmeyer LM Jr, et al. Among authors: vereb g jr, vereb g. IUBMB Life. 2003 Feb;55(2):59-65. doi: 10.1002/tbmb.718540873. IUBMB Life. 2003. PMID: 12749687 Free article. Review.

2

Nucleolar localization of phosphatidylinositol 4-kinase PI4K230 in various mammalian cells.

Kakuk A, Friedländer E, Vereb G Jr, Kása A, Balla A, Balla T, Heilmeyer LM Jr, Gergely P, Vereb G. Kakuk A, et al. Among authors: vereb g jr, vereb g. Cytometry A. 2006 Dec 1;69(12):1174-83. doi: 10.1002/cyto.a.20347. Cytometry A. 2006. PMID: 17131383 Free article.

3

Nuclear and nucleolar localization signals and their targeting function in phosphatidylinositol 4-kinase PI4K230.

Kakuk A, Friedländer E, Vereb G Jr, Lisboa D, Bagossi P, Tóth G, Gergely P, Vereb G. Kakuk A, et al. Among authors: vereb g jr, vereb g. Exp Cell Res. 2008 Aug 1;314(13):2376-88. doi: 10.1016/j.yexcr.2008.05.006. Epub 2008 May 27. Exp Cell Res. 2008. PMID: 18585705

4

Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.

Liebl J, Krystof V, Vereb G, Takács L, Strnad M, Pechan P, Havlicek L, Zatloukal M, Fürst R, Vollmar AM, Zahler S. Liebl J, et al. Among authors: vereb g. Angiogenesis. 2011 Sep;14(3):281-91. doi: 10.1007/s10456-011-9212-6. Epub 2011 Apr 13. Angiogenesis. 2011. PMID: 21487803

5

Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance.

Barok M, Isola J, Pályi-Krekk Z, Nagy P, Juhász I, Vereb G, Kauraniemi P, Kapanen A, Tanner M, Vereb G, Szöllösi J. Barok M, et al. Among authors: vereb g. Mol Cancer Ther. 2007 Jul;6(7):2065-72. doi: 10.1158/1535-7163.MCT-06-0766. Mol Cancer Ther. 2007. PMID: 17620435

6

Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.

Friedländer E, Arndt-Jovin DJ, Nagy P, Jovin TM, Szöllosi J, Vereb G. Friedländer E, et al. Among authors: vereb g. Cytometry A. 2005 Oct;67(2):161-71. doi: 10.1002/cyto.a.20173. Cytometry A. 2005. PMID: 16163699 Free article.

7

ErbB-directed immunotherapy: antibodies in current practice and promising new agents.

Friedländer E, Barok M, Szöllosi J, Vereb G. Friedländer E, et al. Among authors: vereb g. Immunol Lett. 2008 Mar 15;116(2):126-40. doi: 10.1016/j.imlet.2007.12.001. Epub 2007 Dec 26. Immunol Lett. 2008. PMID: 18201769 Review.

8

Molecular modeling of nearly full-length ErbB2 receptor.

Bagossi P, Horváth G, Vereb G, Szöllösi J, Tözsér J. Bagossi P, et al. Among authors: vereb g. Biophys J. 2005 Feb;88(2):1354-63. doi: 10.1529/biophysj.104.046003. Epub 2004 Dec 13. Biophys J. 2005. PMID: 15596490 Free PMC article.

9

ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment.

Váradi T, Roszik J, Lisboa D, Vereb G, Molina-Guijarro JM, Galmarini CM, Szöllosi J, Nagy P. Váradi T, et al. Among authors: vereb g. Eur J Pharmacol. 2011 Sep 30;667(1-3):91-9. doi: 10.1016/j.ejphar.2011.05.064. Epub 2011 Jun 2. Eur J Pharmacol. 2011. PMID: 21658382

10

Commissural propriospinal connections between the lateral aspects of laminae III-IV in the lumbar spinal cord of rats.

Petkó M, Veress G, Vereb G, Storm-Mathisen J, Antal M. Petkó M, et al. Among authors: vereb g. J Comp Neurol. 2004 Dec 20;480(4):364-77. doi: 10.1002/cne.20356. J Comp Neurol. 2004. PMID: 15558798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page